NewsRoom Articles - Page 12 of 251

WednesdayMay 29, 2024 11:15 am

Golden Triangle Ventures Inc. (GTVH) Subsidiary Shares New Business Model Based on Key Pillars to Ensure Success

Strategic four-pillar business model provides essential piece of Lavish Entertainment’s mission to create an industry-leading entertainment business New model “represents a bold step forward in our journey to develop Lavish Entertainment into a staple in the entertainment industry,” states CEO The company plans to develop, acquire operations in each of plan’s four areas At the core of Golden Triangle Ventures’ (OTC: GTVH) purpose of pursuing ventures in the health, entertainment and technology sectors lies its focus on vertical integration to cut costs and maximize margins. One of the company’s newest ventures — Lavish Entertainment, its entertainment division — embodies this…

TuesdayMay 28, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024

Lexaria, a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 GLP-1, a class of drugs, has demonstrated the ability to address diabetes and weight loss, albeit with poor oral bioavailability, usually as little as 0.8% Lexaria, through its study, looks to demonstrate the effectiveness of its DehydraTECH(TM) technology in improving GLP-1’s bioavailability, opening up a vast worldwide market Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just concluded its first dosing for its glucagon-peptide-1 (“GLP-1”) human pilot study #2, GLP-1-H24-2 (https://cnw.fm/g0mZl). This follows the recent…

TuesdayMay 28, 2024 10:00 am

New Iowa Law Bans Intoxicating Hemp Derivatives, Imposes Restrictions on CBD

Governor Kim Reynolds of Iowa recently signed a measure that bans synthetically produced delta-8 THC and other laboratory-made intoxicating compounds. Other popular intoxicating hemp compounds that are banned include THCP, THC-O-acetate, delta-10 THC and THCA. Data from national poison control centers revealed that between 2021 and 2023, almost 8,000 individuals reported terrible effects after consuming products that contained intoxicating hemp compounds. The bill, Iowa House File 2605, also limits the use and sale of naturally derived CBD to individuals aged 21 years of age and older. CBD (cannabidiol) is one of the two primary compounds found in the cannabis plant,…

ThursdayMay 23, 2024 10:00 am

Republican House Leaders Want Farm Bill to Reduce Regulatory Barriers Faced by Hemp Growers

Republican leaders in the house have presented a draft version of a large-scale agriculture bill that could decrease regulatory barriers for some hemp farmers and curtail a ban on industry participation by individuals with previous drug felony convictions. The bill is notably silent on provisions that would ban cannabinoid products derived from hemp. The House Agriculture Committee released the draft farm bill last week, building upon the federal legalization of hemp in several ways. The current draft revises hemp’s definition, establishing different categories for industrial hemp producers who grow the crop for grain, oil, fiber and seed not intended for…

TuesdayMay 21, 2024 2:00 pm

Opinions Divided on How Upcoming Farm Bill Should Regard Intoxicating Hemp Derivatives

Marijuana companies, state regulators, hemp businesses, prohibitionists and Congressional lawmakers are all scrambling to see their priorities addressed in the upcoming farm bill. While there are some points of agreement by various groups, the points on which they differ are generating measurable tension. For example, hemp industry actors are disturbed that some marijuana companies have allied with prohibitionists to see some hemp derivatives outlawed. Edward Conklin, executive director of the United States Cannabis Council (“USCC”), sent a letter to select Congressional leaders in April. He indicated that it was complicated to make policy changes regarding hemp and requested that urgent…

ThursdayMay 16, 2024 10:00 am

Canadian Uniform Maker, Hemp Processor Receive $4.5M to Make Textiles

Financing amounting to $4.5 million has been availed to bolster the supply chain of hemp through the production of uniforms in Alberta, Canada. Of this amount, $3.65 million will be provided to Askiy Hemp LP by the Canadian federal government. Askiy has plans to set up an industrial plant to process industrial hemp within Elk Point. In addition, the provincial government of Alberta will inject $804,000 in Logistik Unicorp, a company that makes uniforms. The intention of this initiative is to convert locally grown hemp in Frog Lake and Elk Point into a variety of products, starting with textiles. Indigenous…

TuesdayMay 14, 2024 10:00 am

Illinois Lawmakers Want More Oversight of Hemp Industry

Lawmakers in Illinois are calling for increased oversight over the state’s largely unregulated hemp derivatives market. This market ballooned in the years after the 2018 Farm Bill legalized industrial hemp and hemp extracts across the United States under state and tribal programs. In the wake of this legislation, many businesses took advantage of legal loopholes to process and sell hemp derivatives such as cannabidiol (“CBD”), and delta-8 THC. While these derivatives technically aren't illegal under federal law, there are few if any federal or state regulations governing their production and sale. As a result, Illinois and other states with hemp…

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

ThursdayMay 09, 2024 10:00 am

USDA Data Shows Hemp Acreage Shrinking in Midwest

A recent report authored by the U.S. Department of Agriculture indicates that the quantity of hemp being cultivated by farmers in the Great Plains and Midwest region of the country has reduced in comparison to what it was two years prior. However, one research experts sees this reduction as something good. David Lakeman, head of the department of agriculture in Illinois, says the explosive interest in growing hemp after the enactment of the 2018 Farm Bill through which hemp was legalized resulted in the value chain for the plant being overwhelmed. He notes that there was a need to establish…

ThursdayMay 09, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance

Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per…

News and publishing service for hemp related companies

Contact us: 512.354.7000